Saba Capital Management, L.P. sold HQL
March 24, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 2,329 shares of Abrdn Life Sciences Investors at $13.21 per share, a transaction worth $30.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,329
Price
$13.21
Total value
$30.8K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 24, 2025
Filing dateMarch 25, 2025
Shares owned after3,273,552
OwnershipIndirect
10b5-1 planNo
AmendedNo